Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation in Potential Priority Review Voucher Value
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| ATOSSA GNTCS (NASDAQ: ATOS) | Delayed: 2.72 +0.19 (7.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.53 | 52 Week High | $3.64 | |||
| Open | $2.49 | 52 Week Low | $0.14 | |||
| Day High | $2.77 | P/E | N/A | |||
| Day Low | $2.46 | EPS | $0.00 | |||
| Volume | 90,657 | |||||
